Brent Zanke
Founder at ArcticDX, Inc.
Profile
Brent Zanke is the founder of ArcticDX, Inc. where he holds the title of Director starting in 2006.
Dr. Zanke is also the founder of CTRL Therapeutics, Inc. Dr. Zanke's former job was as Director at Cross Cancer Institute.
Dr. Zanke earned a doctorate degree from the University of Toronto in 1993 and another doctorate degree from the University of Manitoba in 1983.
Brent Zanke active positions
Companies | Position | Start |
---|---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Founder | 2010-06-09 |
Former positions of Brent Zanke
Companies | Position | End |
---|---|---|
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Cross Cancer Institute | Director/Board Member | - |
Training of Brent Zanke
University of Toronto | Doctorate Degree |
University of Manitoba | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |
Cross Cancer Institute | |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Brent Zanke